Why Is Medpace Stock Diving On Tuesday?
Financial Performance: Medpace Holdings reported an 8.3% year-over-year revenue increase to $533.3 million for Q3, missing expectations, while EBITDA rose 31.7%. The company also lowered its FY24 revenue forecast and noted a net book-to-bill ratio of 1.00x.
Market Reaction and Analyst Insights: MEDP shares fell 8.76% following the earnings report, with analysts suggesting that elevated cancellations may have affected bookings. Despite this, there is potential for investors to buy the dip if gross bookings stabilize and management clarifies the situation.
Trade with 70% Backtested Accuracy
Analyst Views on AMID

No data
About the author


New ETF Launches: Argent Capital Management has introduced two new ETFs, the Argent Large Cap ETF (ABIG) and the Argent Focused Small Cap ETF (ALIL), complementing their existing Mid Cap ETF (AMID) to provide a comprehensive U.S. equity exposure strategy focused on investing in high-quality companies with strong cash flows and competitive advantages.
Investment Philosophy: The firm emphasizes a research-driven approach, prioritizing long-term growth through disciplined capital allocation and a focus on enduring businesses, while maintaining a cautious stance towards sectors like healthcare and unprofitable biotech firms.
CDW Corporation Financial Results: CDW reported a 2% decline in net sales for Q3 FY2024, totaling $5.517 billion, which fell short of expectations. The Corporate segment saw a 4.4% decrease, while the Public segment dropped by 5.1%, attributed to reduced sales to Government and Education customers.
Dividend Announcement and Stock Performance: Despite the disappointing results, CDW raised its quarterly cash dividend by 1% to $0.625 per share. However, shares fell nearly 10% to $197.93 following the earnings report, with CFO citing economic uncertainty as a factor in project delays.
Financial Performance: Medpace Holdings reported an 8.3% year-over-year revenue increase to $533.3 million for Q3, missing expectations, while EBITDA rose 31.7%. The company also lowered its FY24 revenue forecast and noted a net book-to-bill ratio of 1.00x.
Market Reaction and Analyst Insights: MEDP shares fell 8.76% following the earnings report, with analysts suggesting that elevated cancellations may have affected bookings. Despite this, there is potential for investors to buy the dip if gross bookings stabilize and management clarifies the situation.

Leadership Changes at Builders FirstSource: Builders FirstSource has appointed Peter Jackson as the new President and CEO, succeeding Dave Rush, who is retiring after 25 years. Pete Beckmann will take over as CFO, effective November 6, 2024.
Financial Performance and Stock Movement: The company reported strong second-quarter earnings of $3.50 per share, exceeding expectations, although sales fell slightly short. Following these announcements, BLDR shares rose by 3.09% to $200.53.
- CDW Corp Earnings Report: CDW Corp reported lower-than-expected fiscal first-quarter 2024 results with a decline in net sales and adjusted EPS missing consensus.
- Segment Performance: Net sales from Corporate, Small Business, and Public segments all declined year-over-year.
- International Operations: Net sales for CDW's U.K. and Canadian operations combined fell 6.5% year-over-year.
- Financial Metrics: Average daily sales decreased, but gross margin expanded. Adjusted operating margin slightly decreased.
- Market Outlook: CDW CFO mentioned weaker IT market conditions impacting customer spending decisions, but the company aims to exceed US IT market growth rates.








